Menu
GeneBe

ZNF277

zinc finger protein 277, the group of Zinc fingers C2H2-type

Basic information

Region (hg38): 7:112206694-112343934

Previous symbols: [ "ZNF277P" ]

Links

ENSG00000198839NCBI:11179OMIM:605465HGNC:13070Uniprot:Q9NRM2AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ZNF277 gene.

  • Inborn genetic diseases (15 variants)
  • not provided (7 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ZNF277 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
2
missense
13
clinvar
3
clinvar
16
nonsense
0
start loss
0
frameshift
1
clinvar
1
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
2
2
non coding
1
clinvar
1
Total 0 0 13 6 1

Variants in ZNF277

This is a list of pathogenic ClinVar variants found in the ZNF277 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
7-112206716-A-G Likely benign (Aug 01, 2023)2657946
7-112206733-C-T not specified Uncertain significance (Jan 26, 2022)2273306
7-112206790-G-A not specified Uncertain significance (Apr 06, 2022)2206126
7-112286866-A-T Likely benign (Jul 14, 2017)777630
7-112286869-C-T Likely benign (Jul 14, 2017)777631
7-112286899-C-T not specified Uncertain significance (Oct 05, 2022)2395623
7-112286924-G-A not specified Uncertain significance (Jul 26, 2022)2209553
7-112286942-G-A not specified Uncertain significance (Oct 20, 2021)2256209
7-112295880-A-T not specified Uncertain significance (Jan 03, 2024)3194836
7-112295949-C-G not specified Uncertain significance (Jun 13, 2022)2403114
7-112296237-G-A Likely benign (Apr 01, 2022)2657947
7-112296282-C-T not specified Uncertain significance (Feb 16, 2023)2468342
7-112315892-AAGATTTTAATGCTGCCCGACCTCTCCAGATCACTGTCCCCTGGCTTCTGAAGTTGTTTGTTCACTAAATAAGAAGGTCATTGTTCTAAGCTCTGTATCGACATGTGCTACAATGGGTACCTTCTGAGAAAAAATTAAAAGTGATATCATGAAAATAGCACCAAATTTGGCACCAAGTAGCTATGCAGCTTTAAACAAATCCCCTAACATCTCTTACAGGGAGTCAGTAGATAGTTTCATGAGATCCCTTTCAGCTGTCATGTTGTAAAAAGCCAGTTCTACACAATATTGGTCAGAAAGAAAATCTTACTAGAGTAGAGAGGTTAGATGTAGTTAGTAGAAATAGAATATATTAATGGGGAACACTGGAAAAATTGTCTTTTAAGAAGTGTCTGTTCATATCCTTTGCCCACTTTTTGAAGGGTTTGTTGGTTTTTTTCATATATTTCTTGGCTGTATAAGTGTCCTCTTTTGAGAAGTGTCTGTTTATATCCTTTGCCCACTTTTTCATATGATTGTTTGTTTTTTTCTTGTAAATTTGTGTAAGTTCCTTGTAGATTCTGGATATTAGCCCTTTGTCAGATGGATAGATTGCAAAAATTTTCTCCCGTTCTGTAGGTTGCCTGTTCATTCTGATGATGGTTTCTTTTGCTTGCAGAAGCTTTCTAGTTTAATTAGATCCCATTTGTCAATTTTGGCTTTTGTTGCCATTGCTTTTGGTGTTTTAGTCATGAAGTCTTTGCCCTTGCCTATGTCCTGAATGGTATTGCCTAGGTTTTCTTCTAGGGTTTTTATGCTTTAGAGTGTTGATGGGAGTATAAATTAGTTCAACCATTGTGGAAGACGGTGTGGCAATTCCTCAAGGATCTTGAGCCAGAAATACCATTTGACTCAGCGGTCCCGTTACTGTGTATATACCCAAATGATTATAAATCATTCTACTATAAAGACACATGCACACATATGTTTACTGCAACACTATTCACAACAGCGAAGACTTGGAACCAACCCAAATGCCCATCAATGATAGACTGGATAAAGAAAATGTGGCACATATACACCATGGAATACTATGCAGCCATAAAAAGGGCAAGTTCATGTCCTTAGCAAGGACATGGATGAAGCTGGAAACCATCATTCTCAGCAAACTAACACAGGAACAGAAAACCAAACACCACATGTTCTCACTCATAAGTAAGAGTTGAACAATGAGAACACATGGACGCAGGGAGGGAACATCATACACCAAGGCCTATCAGGGGTTGAGGGGCTAGGGAAGGGATAATATTAGGAGAAATACCTAATGTAGATGATGGGTTGATGGGTACAGCAAACCACCATGGCACATGTGGCACATGTCACTATGTAACAAACCTGCATGATCTGCACATGTATCCCAGAACTTAAAGTGTAATAAAAAATTAAAAAAGAGAAAACTGAGGATTAAAGAAGTTAAATATCAATTATATGTGAGAGCCATATTTCAAATCCAGATCTGCTCCATGTTTCAGAGCCTGAGCTCTTAACTGTTGTACTGTGGCCAGAAATGGTTGCACGATAGAAATAGGAATCAAGTGGGATCTTGATTAGCAGATAAGATTTGTGAAAGTGAAAAAGAAAAAGGAAATAAAATGACCTCAGGAAAAATAACATATGGAACCACCTTGATTAGAGCAGGATATTATCAGAGCATATTTTAAATTATTTGAGTTGAGATGCAACAAGTTAATTATGCATGAAAATATTAAGAAAAATTCTAGCAGCAAAAAGAGGATGAATATGTTAGAAAAGGGATTGAAATCAGGGAGAACCTTTAGGAGACTTTATTTATGGTAACCCACAATGACTAAAAACTGAACTCAGAGGGGTGACCTTGGGAATGGTAGAGAAAAGTTATATGGAAGATAGTTCAAATGAAAAATTGATCAGAACTTGATTACAAATCAAACTGAGAATTAGGGAAAAGAGCAAGTCAAAGATCCCAGCACAATTTTGGTTTTGGAAGAGGATAGGGATGGGAAAACACTGGAAAAGACAGGGTAGCAAAGGACGGTAAAACCTTGTTGATTTTAATTCCCACATAGCTGTTAAAGTGGAGTGTTCTGTAAGCATTTTATGGGACAGACTTGGAGTTTAATGCAAAAACAGGAATGGAGAAATTTGAAATGTTGGCAACTTTTATATACTCCCTTTATGCTTCCAGCCCAGTTTCCTCCCATCCAGACTTTGACATTTTTTATTAGCCAATTGTGCATTAAGATAATACCATAAATCTGTTTCTACTTTCCAGAGAGAAATTCTGGAACAACAGCAGCAAGAACGAAATGATACCAATTTTCATGGCGTTTGTATGTTTTGCAATGAAGAATTCCTTGGAAACAGGTTTGCCATTTTGCATCTTTAAATGTTACTGTTTTTAATCTGAAAACTCATCAGAACATCCCTAACTGTTGGTTATATAAATTAAGTTCTATGTGTTGGCTCAGGACCCTTTCGTATATAAGCAGTCCTTTTTAAAAATATACCCAACGTCCAAGATGAACTGTAGGTGCTCTAAGCAGCAGAGGGGTATAAATTCTTAAAATGACAGAAGCAGATTTATGTTTAATATTACAGGACTTTTAAAATTGGCTGACCTGCAAGACCATATGCAGCAAACTACTGCAGATGCACCTCTGTATACTAACTCTTTTCTTCTAAATCATTGGTAACTTTTCACTTTTGGTTATTAAAAATAAAGACATAAAAAAGAAGTGGGGGCACTGGTGATTCTATCACCAACCCCAGCTGGTCCAAAACCAGCTGGTGCAGTACAATTCAATTCTGGCACTAATCACCTGGGATTAGCATAAGGTTTTACATATTTAAGGGCACAGGCTCAAACAAGACTGCCTTCACATTAGACACCAGCCATAAACTCATATGGTCCCAGGGCTACCCAAAGTTTTGACCACTGGTTATAAAGTCAGAGGTTCCCACTGATAATTTCATGGGTTTGATAATTTGCTAGAATTACTTACAGAACTCAGGAAAGCACTGTACTTATGATTACAGTTTTACTATAAAGGATACAGATTAGAAACAGCCAAATGAAGAGACAAATTGGGCAGGGTCTGAGAGGGTCCTGAATAAGGAGTTTCTGAATCCTCTTCCCAAGGAATTAGGACCTGTCACCTTCCTAGCACATTAAGGAATTCAGCAACCAGCAACCTACTCTGAGTTTTGGTGTCCCAAGTTTTTATTAGGACTTCATTATGTAGGTATGATTGATTAAATTATTGAACTCAATCAGCAGCCCCCTCCCCTCTCTGGAGGTCTGACTGGCTCAAAGTCCCAACCCTCTAATCATATGGTTGGTCTTTATGATGAACATTCCCCATCTGGAAGCTATGTAGGGTCCTACCATGAGTCTCCTCATTCATATAATAAAGATACTCCTATCACTAGAAAAATTACTAGAAACTTTGTGCTAGGGACAAGAGACAAAGAGCAGACACATTTATTATTACGCATCAGCAATGTTTACAAATATACATTCACTTAAATACAAGTTATGAAGTTGTAACCTCTAGGAACTGAGGATGATTTCACTGATTCAGCATACAGGGGACAATCAGAAAAATATCATTCTCTGCTCACTTGAAAGAAAGCAGTCTTTAGTGAAAACATAGCCCAGCACAGTAACTGACATTGTTATGTGAAAAACCTTGGAAAGGAGAAGGTAGCCACTTATTGGAATTTATAAATTATAATTTATAAATTATATAATATATATAATATATATTATATAAATTATATAAATTTATAAATTAAATTTATAAATTATAAAAGAGTTTAATTGAGGCATTAATGTTCAAAACACCAGTGGTAAAGGTTTGATTCTCAGATCAGTTAGCATAGAGAAAAATCGGTGCCAAGGCCACTGATCGTACTTCTAACTTTGTCCTTCTATTTCAAAGGACTTTACGGGCATAACAATAAAGGCTGGTCTTAAAAGTTAACTTAAAAGTACCAGTGAAAACCCATGCCACCATCAGAAAATTTACCAAACATTACTACTGACAATGTTTTAACAAAATATTTCCGATTTTATGTTGAGGTAATTATTGACCTAGTGAGGAGGCATGTGATTATCATCAGAGATCTCTCATATC-A Uncertain significance (Oct 01, 2014)157510
7-112318211-A-G Likely benign (Aug 01, 2023)2657948
7-112318220-T-TA Benign (Dec 18, 2017)713971
7-112318225-A-G not specified Likely benign (Oct 06, 2022)2381733
7-112330157-C-T not specified Uncertain significance (Apr 07, 2022)2213603
7-112330173-C-G not specified Uncertain significance (May 23, 2023)2512451
7-112336140-G-T not specified Uncertain significance (Jan 04, 2022)2269443
7-112337735-G-C not specified Uncertain significance (Sep 16, 2021)2353258
7-112337764-G-T not specified Uncertain significance (Dec 06, 2022)2333618
7-112339855-T-C not specified Uncertain significance (Jul 12, 2022)2300872
7-112340936-A-T not specified Uncertain significance (Jan 08, 2024)3194835
7-112340997-A-G not specified Likely benign (Jul 08, 2022)2408176
7-112341032-G-A Likely benign (Apr 01, 2022)2657949

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ZNF277protein_codingprotein_codingENST00000361822 12136509
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
8.32e-220.000260124745169871257480.00400
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.3472132280.9350.00001073014
Missense in Polyphen7071.1990.98317991
Synonymous0.1048283.20.9850.00000434752
Loss of Function-0.7043026.11.150.00000121334

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.02680.0268
Ashkenazi Jewish0.0002980.000298
East Asian0.0008200.000816
Finnish0.002450.00236
European (Non-Finnish)0.0003270.000325
Middle Eastern0.0008200.000816
South Asian0.0004910.000490
Other0.002780.00277

dbNSFP

Source: dbNSFP

Function
FUNCTION: May be involved in transcriptional regulation.;

Recessive Scores

pRec
0.105

Intolerance Scores

loftool
0.917
rvis_EVS
0
rvis_percentile_EVS
53.73

Haploinsufficiency Scores

pHI
0.122
hipred
N
hipred_score
0.292
ghis
0.604

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.975

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Zfp277
Phenotype
cellular phenotype;

Gene ontology

Biological process
regulation of transcription by RNA polymerase II;cellular response to hydrogen peroxide;regulation of cellular senescence
Cellular component
nucleus
Molecular function
RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;metal ion binding